Stock screenerAll disclosures → EDGAR →
OCGN
Conviction 32HealthcareScan · Thu, Jun 25, 2026OCGN$1.37-1.80%
ResistanceSupportVol 14Vol MA14 8.84M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.37
Change-1.80%
Gap+2.88%
Rel volume4.19×
Avg volume7.95M
Avg $ vol10.34M
SMA 201.29
SMA 501.47
SMA 2001.54
Price vs 50-6.97%
Price vs 200-11.23%
MA stackbearish
50/200 crossdeath · 6d
Supertrenddown · 1.40
RSI (14)52
MACD hist0.03
MACD crossbull · 7d
Stoch %K / %D66 / 74
ADX (14)23
+DI / −DI25 / 18
RSI divergence—
MACD divergence—
ATR %+6.30%
ADR %5.72%
52w high2.48
52w low0.9241
From 52w high-44.96%
Above 52w low+47.71%
New 52w highNo
SqueezeOff
Bollinger width22.87%
%B0.74
Donchian pos66.13%
Donchian high1.47
Donchian low1.16
AVWAP (52w high)1.65
vs AVWAP high-17.29%
AVWAP (52w low)1.59
vs AVWAP low-13.97%
OBV trendFlat
Chaikin MF (20)-0.55
Today vs 20d4.19×
Avg vol (14d)8.84M
Avg vol (20d)7.95M
Avg $ vol (20d)10.34M
Market cap462.08M
RS 3m (vs SPY)-39.86%
RS 6m (vs SPY)-8.45%
RS line new highNo
Trend template3/8
Technical rank33.5
1 week+10.98%
1 month+1.87%
3 months-30.00%
6 months-7.77%
1 year+31.88%
YTD-1.09%
P/E-6.81
P/B79.60
P/S104.71
P/FCF-8.09
EPS-0.2600
Div yield—
ROE—
ROA-119.23%
Debt/Eq5.03
Current1.86
EV/EBITDA-7.36
Gross margin—
Net margin—
Rev growth8.83%
EPS growth-25.52%
Price target9.67
Target upside608.42%
Analyst ratingBuy
Institutional37.73%
Ent. value459.38M
Revenue1.53M
Net income-19.18M
Gross profit—
Free cash flow-57.15M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out338.52M
Employees116
ListedWed, Dec 3, 2014
Free float298.14M
Float %95.5%
Short interest83.02M
Days to cover14.3d
Short volume60.5%
Squeeze score94 / 100
Next earningsFri, Aug 7, 2026 (43d)
EPS forecast−$0.05 · 3 est
Last EPS vs est−$0.06 vs −$0.05
Last surprise-20.0% miss
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank33.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.75
Support1.17
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in OCGN
No recent disclosed trades by Congress in OCGN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OCGN
No recent insider (Form 4) filings in OCGN. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in OCGN · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.